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Objectives: 
To assess the role of COCP as add back therapy in alleviating vasomotor symptoms in patients receiving GnRH 
analogue. 
 
Methods: 
This was a randomised control trial involving 25 patients on GnRH analogue in a university hospital over period of 
six months. The patients were randomised into two groups, twelve patients were treated with GnRH analogue and 
low dose COCP (treatment group) as add back therapy and thirteen patients were treated with GnRH analogue alone 
(control group) for three months. 
 
Results: 
There were no significant differences in socio-demographic data between both groups except for BMI (p=0.034). 
There were significant difference observed among both groups in term of hot flushes (p=0.008), night sweat 
(p=0.010) and vasomotor symptoms (p=0.004) at the end of third month. There were also significant differences in 
term of bleeding pattern in which women in the treatment group experienced more bleeding episodes. However no 
differences in haemoglobin level in patients in both groups. Besides that, there were also noted significant 
differences in pad usage in both groups. With regards to side effects of low dose COCP, headache had p value of 
0.001 which is statistically significant. There were no significant differences in term of vaginal dryness and weight 
differences between two groups before and after treatment with COCP. 
 
Conclusion: 
This small study strongly suggests that low dose COCP is a safe and tolerable as add back therapy as it resulted in a 
significant reduction in vasomotor symptoms at the end of third month in treatment group. However patient may 
experience bleeding irregularities and headache. Therefore it can be considered as a safe alternative to other add back 
therapy for a better quality of life. 
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